Pre-market Hot Trades in US Stocks
Synergy CHC is down 10.65% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 14, Synergy CHC submitted an S-8 filing to register approximately 2.25 million shares of common stock for employee and executive compensation plans. This move may lead to price pressure as the market is concerned about equity dilution.
</li>
<li>
On April 14, Ascendiant Capital maintained a buy rating and raised the target price from $5 to $5.50, driving the stock price up.
</li>
<li>
On April 14, Synergy CHC's stock price surged from $0.58 to about $1.15 in after-hours trading, an increase of nearly 100%, reflecting market optimism about its short-term performance. The market reacted significantly to equity dilution and rating changes.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Immutep is up 188.02% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 15, Immutep received FDA orphan drug designation for the treatment of soft tissue sarcoma. This designation supports potential late-stage development, with trials achieving primary endpoints in 38 evaluable patients, showing a median tumor transparency/fibrosis of 51.5%. This news significantly boosted market confidence, driving the stock price up sharply.
</li>
<li>
On April 13, Immutep's Chief Operating Officer Deanne Diem Miller submitted an initial beneficial ownership statement, reporting ownership of 2,867,305 common shares. This move demonstrates the confidence of company executives in the future development of the company, further enhancing investor confidence.
</li>
<li>
On April 13, Immutep's CEO Marc Voigt submitted an initial Form 3, showing ownership of 14,792,145 common shares. The increase in executive shareholding is typically seen as a positive signal for the company's future prospects, further driving the stock price up. Market attention on the biotech sector has increased, with noticeable capital inflows.
</li>
</ol>
Allbirds is up 106.42% in pre-market trading. Based on recent key news:
<ol>
<li>
On April 15, Allbirds signed a $50 million convertible financing agreement with an institutional investor. This agreement is expected to be completed in the second quarter of 2026, allowing the company to transform into an AI computing infrastructure provider and plans to rename itself &#34;NewBird AI.&#34; This news drove the stock price up nearly 17%.
</li>
<li>
On April 15, Allbirds announced the cancellation of the earnings call originally scheduled for that week, and related financial data will no longer be released. This move raised market uncertainty about the company's future, but the financing agreement news alleviated some concerns.
</li>
<li>
On April 14, market analysis pointed out that Allbirds' minimalist style has become dull in the eyes of consumers seeking individual expression, leading to brand image damage. Nevertheless, the announcement of the financing agreement brings new development opportunities for the company
The DTC model faces challenges, and brands need to innovate.
</li>
</ol>
Allied Gaming &amp; Entertainment pre-market rose 55.52%. Based on recent key news:
<ol>
<li>
On April 14, Allied Gaming &amp; Entertainment announced a comprehensive solution and strategic path with Knighted Pastures. This move eliminated legal disputes between the two companies, enhanced market confidence, and significantly boosted stock prices.
</li>
<li>
On April 14, Allied Gaming &amp; Entertainment stated that under the terms of the solution, the company has no doubts about Knighted Pastures' operational practices or integrity. This news further stabilized investor sentiment and promoted stock price increases.
</li>
<li>
On April 14, retail trader sentiment shifted from &#34;bearish&#34; to &#34;extremely bullish,&#34; with news volume increasing from &#34;normal&#34; to &#34;very high.&#34; This shift in sentiment reflects the market's optimistic attitude towards the company's prospects, driving stock prices up. Market sentiment is optimistic, trading is active, and volatility risks need to be monitored
</li>
</ol>

SNYR

Synergy CHC pre-market down 10.65%; Immutep pre-market up 188.02%; Allbirds pre-market up 106.42%; Allied Gaming & ENT pre-market up 55.52%

Pre-market hot trades in US stocks: Synergy CHC pre-market down 10.65%, concerns over equity dilution suppress market optimism